Establishment Labs (ESTA)
(Delayed Data from NSDQ)
$48.81 USD
+0.91 (1.90%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $48.72 -0.09 (-0.18%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ESTA 48.81 +0.91(1.90%)
Will ESTA be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for ESTA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ESTA
Sera Prognostics, Inc. (SERA) Reports Q3 Loss, Lags Revenue Estimates
Avantor, Inc. (AVTR) Beats Q3 Earnings Estimates
ESTA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates
Establishment Labs (ESTA) Surges 7.4%: Is This an Indication of Further Gains?
Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Tops Revenue Estimates
Other News for ESTA
Exploring Establishment Labs Hldgs's Earnings Expectations
Nantahala Capital Management's Strategic Acquisition in Evoke Pharma Inc
Establishment Labs Holdings Inc (ESTA) Q3 2024 Earnings Report Preview: What To Look For
Nantahala Capital Management Reduces Stake in Eagle Pharmaceuticals
Establishment Labs Holdings Inc (ESTA) Shares Up 4.13% on Nov 5